𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adalimumab improves patient-reported outcomes and reduces indirect costs in patients with moderate to severe Crohn's disease: Results from the CARE trial

✍ Scribed by Louis, Edouard; Löfberg, Robert; Reinisch, Walter; Camez, Anne; Yang, Mei; Pollack, Paul F.; Chen, Naijun; Chao, Jingdong; Mulani, Parvez M.


Book ID
120039169
Publisher
Oxford University Press
Year
2013
Tongue
English
Weight
448 KB
Volume
7
Category
Article
ISSN
1873-9946

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES